These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Further evidence for the role of histamine H3, but not H1, H2 or H4, receptors in immepip-induced inhibition of the rat cardioaccelerator sympathetic outflow. Pinacho-García M, Marichal-Cancino BA, Villalón CM. Eur J Pharmacol; 2016 Feb 15; 773():85-92. PubMed ID: 26826593 [Abstract] [Full Text] [Related]
3. Pharmacological evidence that dopamine inhibits the cardioaccelerator sympathetic outflow via D2-like receptors in pithed rats. Alcántara-Vázquez O, Villamil-Hernández MT, Sánchez-López A, Centurión D. J Pharmacol Sci; 2013 Feb 15; 123(4):380-91. PubMed ID: 24225403 [Abstract] [Full Text] [Related]
4. The role of dopamine D2, but not D3 or D4, receptor subtypes, in quinpirole-induced inhibition of the cardioaccelerator sympathetic outflow in pithed rats. Altamirano-Espinoza AH, González-Hernández A, Manrique-Maldonado G, Marichal-Cancino BA, Ruiz-Salinas I, Villalón CM. Br J Pharmacol; 2013 Nov 15; 170(5):1102-11. PubMed ID: 24032529 [Abstract] [Full Text] [Related]
8. The dopamine receptors mediating inhibition of the sympathetic vasopressor outflow in pithed rats: pharmacological correlation with the D(2) -like type. Manrique-Maldonado G, González-Hernández A, Marichal-Cancino BA, Villamil-Hernández MT, del Mercado OA, Centurión D, Villalón CM. Basic Clin Pharmacol Toxicol; 2011 Dec 15; 109(6):506-12. PubMed ID: 21740529 [Abstract] [Full Text] [Related]
9. Chronic 5-HT2 receptor blockade unmasks the role of 5-HT1F receptors in the inhibition of rat cardioaccelerator sympathetic outflow. García-Pedraza JÁ, Hernández-Abreu O, García M, Morán A, Villalón CM. Can J Physiol Pharmacol; 2018 Apr 15; 96(4):328-336. PubMed ID: 28886249 [Abstract] [Full Text] [Related]
10. The role of pre-junctional D2 -like receptors mediating quinpirole-induced inhibition of the vasodepressor sensory CGRPergic out-flow in pithed rats. Manrique-Maldonado G, González-Hernández A, Altamirano-Espinoza AH, Marichal-Cancino BA, Ruiz-Salinas I, Villalón CM. Basic Clin Pharmacol Toxicol; 2014 Feb 15; 114(2):174-80. PubMed ID: 23964609 [Abstract] [Full Text] [Related]
11. The α2-adrenoceptors mediating inhibition of the vasopressor sympathetic outflow in pithed rats: pharmacological correlation with α2A, α2B and α2C subtypes. Villamil-Hernández MT, Alcántara-Vázquez O, Sánchez-López A, Centurión D. Eur J Pharmacol; 2013 Oct 15; 718(1-3):245-52. PubMed ID: 24028939 [Abstract] [Full Text] [Related]
12. Predominant role of the dopamine D3 receptor subtype for mediating the quinpirole-induced inhibition of the vasopressor sympathetic outflow in pithed rats. Ruiz-Salinas I, González-Hernández A, Manrique-Maldonado G, Marichal-Cancino BA, Altamirano-Espinoza AH, Villalón CM. Naunyn Schmiedebergs Arch Pharmacol; 2013 May 15; 386(5):393-403. PubMed ID: 23420100 [Abstract] [Full Text] [Related]
13. Streptozotocin-induced diabetes in rats modifies the role D2 , D3 and D4 dopamine receptors play in cardiac sympathetic inhibition. Rivera-Mancilla E, Altamirano-Espinoza AH, Manrique-Maldonado G, Villanueva-Castillo B, Villalón CM. Basic Clin Pharmacol Toxicol; 2022 Oct 15; 131(4):262-269. PubMed ID: 35834260 [Abstract] [Full Text] [Related]
14. Role of peripheral 5-HT5A receptors in 5-HT-induced cardiac sympatho-inhibition in type 1 diabetic rats. García-Pedraza JÁ, Hernández-Abreu O, Morán A, Carretero J, García-Domingo M, Villalón CM. Sci Rep; 2020 Nov 09; 10(1):19358. PubMed ID: 33168874 [Abstract] [Full Text] [Related]
15. Pharmacological profile of the inhibition by dihydroergotamine and methysergide on the cardioaccelerator sympathetic outflow in pithed rats. Lozano-Cuenca J, Muñoz-Islas E, González-Hernández A, Centurión D, Cobos-Puc LE, Sánchez-López A, Pertz HH, Villalón CM. Eur J Pharmacol; 2009 Jun 10; 612(1-3):80-6. PubMed ID: 19356724 [Abstract] [Full Text] [Related]
16. Pharmacological evidence that 5-HT1A/1B/1D, α2-adrenoceptors and D2-like receptors mediate ergotamine-induced inhibition of the vasopressor sympathetic outflow in pithed rats. Villamil-Hernández MT, Alcántara-Vázquez O, Sánchez-López A, Gutiérrez-Lara EJ, Centurión D. Eur J Pharmacol; 2014 Oct 05; 740():512-21. PubMed ID: 24975101 [Abstract] [Full Text] [Related]
17. Pharmacological profile of 5-hydroxytryptamine-induced inhibition on the pressor effect elicited by sympathetic stimulation in long-term diabetic pithed rats. Morán A, Restrepo B, de Urbina AV, García M, Martín ML, Román LS. Eur J Pharmacol; 2010 Sep 15; 643(1):70-7. PubMed ID: 20547148 [Abstract] [Full Text] [Related]
18. Evidence that some imidazoline derivatives inhibit peripherally the vasopressor sympathetic outflow in pithed rats. Monroy-Ordoñez EB, Villalón CM, Cobos-Puc LE, Márquez-Conde JA, Sánchez-López A, Centurión D. Auton Neurosci; 2008 Dec 05; 143(1-2):40-5. PubMed ID: 18774761 [Abstract] [Full Text] [Related]
19. Pharmacological evidence that histamine H3 receptors inhibit the vasodepressor responses by selective stimulation of the rat perivascular sensory CGRPergic outflow. Manrique-Maldonado G, Altamirano-Espinoza AH, Marichal-Cancino BA, Rivera-Mancilla E, Avilés-Rosas V, Villalón CM. Eur J Pharmacol; 2015 May 05; 754():25-31. PubMed ID: 25704614 [Abstract] [Full Text] [Related]
20. The role of purinergic P2Y12 and P2Y13 receptors in ADPβS-induced inhibition of the cardioaccelerator sympathetic drive in pithed rats. Villanueva-Castillo B, Rivera-Mancilla E, Haanes KA, MaassenVanDenBrink A, Villalón CM. Purinergic Signal; 2020 Mar 05; 16(1):73-84. PubMed ID: 32067141 [Abstract] [Full Text] [Related] Page: [Next] [New Search]